Log In
Print this Print this

Tuberculosis vaccine (MVA85A, MVA85A/AERAS-485)

Also known as: AERAS-485

  Manage Alerts
Collapse Summary General Information
Company Emergent BioSolutions Inc.
DescriptionRecombinant modified Vaccinia Ankara (rMVA) virus expressing Mycobacterium tuberculosis antigen 85A
Molecular Target
Mechanism of ActionVaccine
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationTuberculosis
Indication DetailsPrevent tuberculosis (TB) infection; Prevent tuberculosis (TB) infection in HIV-positive patients
Regulatory Designation
PartnerAeras Global TB Vaccine Foundation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today